ClinicalTrials.govpublic full text
Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
cirrhosis, liver, minimal hepatic encephalopathy, small intestinal bacterial overgrowth, gastrointestinal motility disorder, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 914173
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.